Coffee consumption and risk of hepatocellular carcinoma: A meta-analysis of eleven epidemiological studies

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 4369-4375

  Bai, Kai ^a   Cai, Qiucheng ^a   Jiang, Yi ^a   Lv, Lizhi ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Coffee; Hepatocarcinogenesis; Meta analysis

Indexed keywords

ARTICLE; ASIAN; CANCER RISK; CHRONIC LIVER DISEASE; COFFEE; DRINKING BEHAVIOR; FOOD INTAKE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; META ANALYSIS; QUANTITATIVE STUDY; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 84979633729     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S109656     Document Type: Article

References (40)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics. CA Cancer J Clin. 2015; 65(2): 87-108.
2. Schottenfeld D, Fraumeni FJ Jr. Liver Cancer. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006.
3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118(12): 3030-3044.
4. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-538.
5. Villar S, Ortiz-Cuaran S, Abedi-Ardekani B, et al. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis. PLoS One. Epub 2012 Jun 4.
6. Kumar V, Kato N, Urabe Y, et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet. 2011; 43(5): 455-458.
7. El-Serage HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007; 37(Suppl 2): S88-S94.
8. Plymoth A, Viviani S, Hainaut P. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention. Cancer Lett. 2009; 286(1): 15-21.
9. Kurokawa M, Hiramatsu N, Oze T, et al. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol. 2012; 47(5): 577-585.
10. Azam S, Hadi N, Khan NU, Hadi SM. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit. 2003; 9(9): BR325-BR330.
11. Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signaling pathway. Basic Clin Pharmacol Toxicol. 2008; 102(6): 543-551.
12. Cavin C, Mace K, Offord EA, Schilter B. Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem Toxicol. 2001; 39(6): 549-556.
13. Cavin C, Holzhaeuser D, Scharf G, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002; 40(8): 1155-1163.
14. Inoue M, Yoshimi I, Sobue T, Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005; 97(4): 293-300.
15. Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma. Br J Cancer. 2002; 87(8): 956-959.
16. Kuper H, Tznou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 2000; 85(4): 498-502.
17. Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol. 2005; 42(4): 528-534.
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 557-560.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3): 177-188.
20. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer. 2005; 93(5): 607-610.
21. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res. 2006; 36(3): 201-208.
22. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci. 2007; 98(2): 214-218.
23. Leung WW, Ho SC, Chan HL, Wong V, Yeo W, Mok TS. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study. J Epidemiol Community Health. 2011; 65(6): 556-558.
24. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer. 2007; 120(7): 1555-1559.
25. Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Cause Control. 2011; 22(3): 503-510.
26. Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology. 2015; 148(1): 118-125.
27. Lv X, Chen Z, Li J, et al. Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress. Inflamm Res. 2010; 59(8): 635-645.
28. Furtado KS, Prado MG, Aguiar E, Silva MA, et al. Coffee and Caffeine protects against liver injury induced by thioacetamide in male wistar rats. Basic Clin Pharmacol Toxicol. 2012; 111(5): 339-347.
29. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012; 35(1): 76-82.
30. Lee KA, Chae JI, Shim JH. Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma. J Biomed Sci. 2012; 19: 60.
31. Moreno MG, Chavez E, Aldaba-Muruato LR, et al. Coffee prevents CCI(4)-induced liver cirrhosis in the rat. Hepatol Int. 2011; 5(3): 857-863.
32. Tverdal A, Skutveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol. 2003; 13(6): 419-423.
33. Corrao G, Zambon A, Baqnardi V, D’Amicis A, Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001; 11(7): 458-465.
34. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992; 136(10): 1248-1257.
35. Ong KW, Hsu A, Tan BK. Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS One. Epub 2012 Mar 7.
36. Lin WY, Xaiver Pi-Sunyer F, Chen CC, et al. Coffee consumption is inversely associated with type 2 diabetes in Chinese. Eur J Clin Invest. 2011; 41(6): 659-666.
37. Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital and community-based case-control study. Kurume Med J. 2003; 50(3-4): 91-98.
38. Polesel J, Zucchetto A, Montella M, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2009; 20(2): 353-357.
39. Donadon V, Balbi M, Casarin P, Vario A, Alberti A. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol. 2008; 14(357): 5695-5700.
40. Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012; 28(2): 109-122.